Biofilms In Treating Chronic Sinusitis

Biofilms In Treating Chronic Sinusitis

According to the CDC, chronic rhinosinusitis (CRS) affects approximately 33 million people annually.   In past writings, I discussed the complexities of CRS in that it involves both the anatomy and physiology of the sinuses.  However, research over the past decade has shown besides anatomy and physiology, the infectious agents themselves can also add a whole layer of complexity to CRS that is just beginning to be understood.
When dealing with chronic infectious diseases in general, it must be understood that there is a microcosmic war that is going on in the patient that is suffering.  What has to be appreciated is that these infectious agents will create an environment favorable to them thriving, while creating resistance not only to the host’s defenses but to medical modalities being prescribed such as antibiotics.

It is now becoming well understood that with chronic infections, such as CRS, bacteria have the ability to form an organic matrix made up of polysaccharides, protein and even DNA.  However, to say that this organic matrix forms a protective shield for the bacteria is a gross understatement.   Instead of a shield this organic matrix or glycocalyx behaves more like a 16th-century fortress able to withstand months of an enemy’s siege. 

According to John Costerton’s work in 2003 on bacterial biofilms this glycocalyx is a mosaic of bacterial colonies that possess varying phenotypes and different physiochemical properties.   Not only does this protect the bacterial inhabitants, but it also serves to modulate the microenvironment of these colonies through its numerous canals via a process of interbacterial signaling called quorum sensing.

Biofilms chronic sinusitisJust like in the Siege of Vienna of 1529, Viennese defenders were able to detect the subterranean activities of the Ottoman sappers and miners who were attempting to blow up the cities walls with large amounts of gunpowder.  The defenders were able to sink counter mines in the precise locations trapping and killing many of the enemy.  This is ferocious stuff, but no less ferocious than the war that is going on the sinus cavities of those suffering from CRS.

This is quite the departure from the conventional thinking of chronic infection therapy from when I was training in infectious disease.  Back then, it was thought that bacterial infections caused by isolated bacterial types that would respond to antibiotic therapy.  Unfortunately, as time goes on and more and more patients fail conventional therapy, it is becoming better understood that bacterial behavior is much more complex in chronic infections than initially thought.

One important breakthrough for understanding the complexity of chronic infections is more advanced testing for bacteria than what was previously available.   Even up until today, many clinicians rely on the old Pasturian method of detecting which bacteria is causing infection; however, in many instances, the one species may have dominated the culture, therefore, missing other organisms that could be contributing to the process.  Today we have molecular DNA analysis to help us determine the causative agents.

This is particularly important in CRS.  In many instances, both the clinician and patient are frustrated because the cultures done through conventional methods report no growth, despite the fact the internal endoscopic exam shows inflammation and purulence.  It is my belief that many of these patients have an association with allergic fungal sinusitis, which is even more difficult than bacteria to culture conventionally.
As of right now, myself and my colleagues are using this advanced testing to get a better understanding of the microorganism make-up of patients who suffer from CRS.  My suspicion is that there are many more patients who have a fungal component to their CRS than has been originally thought.  As far as addressing the biofilm, there are several agents that can be used in order to break down the fortress walls.
This advance testing hopefully will help those that have been suffering for years with CRS but have had only very few answers. Comments and Questions always welcome. I hope you enjoyed!

Join My E-Newsletter!

Receive the latest blog posts & take back your health!
SUBSCRIBE NOW
By | 2018-06-04T14:53:29+00:00 May 5th, 2018|Chronic Sinusitis|

About the Author:

I am a passionate blogger, author, speaker and 3X Board Certified MD in Infectious Disease, Internal & Sleep Medicine. I currently am an infectious disease physician in Atlanta, GA for Infectious Disease Consultants.

4 Comments

  1. Lyme Frenz March 3, 2015 at 6:48 pm - Reply

    Would an amphotericin spray address biofilm?

    • Dr. Andrew Pugliese March 6, 2015 at 10:15 am - Reply

      Yes! Amphotericin B does help and we have been using it not only in a spray but direct application to the sinus cavities as a gel with antibiotics and steroids. Thank you for reading and great question!

  2. Dennis Carr May 22, 2015 at 2:12 pm - Reply

    I have suffered from chronic sinus infections for over 12 years with 2 operations to remove polyps. After the 2nd operation (1 yr ago), I have had 3 infections. Today I learned about DNA testing and treatment. Has any of your patients been free of infections since DNA testing and subsequent treatment?

  3. […] more complex infections. This is becoming very evident as we begin to understand the complexity of biofilm and how recalcitrant chronic wounds are to heal through conventional […]

Leave A Comment

WAIT! DON’T MISS OUT!
Subscribe To Newsletter
Be the first to get latest blog posts & take back your health!
Stay Updated
Give it a try, you can unsubscribe anytime.
close-link

Join My E-Newsletter!

Receive the latest blog posts & take back your health!
SUBSCRIBE NOW
close-link
If You Enjoyed This Post
Join My Newsletter
Subscribe
Give it a try, you can unsubscribe anytime.
Close
Sign up and receive the latest blog posts & take back your health!
Subscribe
Subscribe
close-image